×
About 420 results

ALLMedicine™ Unilateral Vocal Fold Paralysis Center

Research & Reviews  165 results

Preliminary Clinical Outcomes of VOIS-Implant in Patients With Unilateral Vocal Fold Pa...
https://doi.org/10.1002/lary.29958
The Laryngoscope; Hsieh LC, Chen CK et. al.

Nov 25th, 2021 - Evaluation of the clinical outcomes after 6 months of treatment with a novel adjustable implant, the APrevent® Vocal-Implant-System (VOIS), in conjunction with medialization thyroplasty (MT) in patients with unilateral vocal fold paralysis. Prospe...

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
https://clinicaltrials.gov/ct2/show/NCT05119842

Nov 15th, 2021 - The APrevent® VOIS is intended to be permanently implanted during a type I thyroplasty in individuals suffering from permanent unilateral vocal fold paralysis of various etiologies. Four post-operative follow-up visits are planned: Week 1 (± 7 day...

Effect of Medialization on Dyspnea Index in Unilateral Vocal Fold Paralysis.
https://doi.org/10.1177/01945998211056515
Otolaryngology--head and Neck Surgery : Official Journal ... Hoffman MR, Vandiver B et. al.

Nov 10th, 2021 - Patients with unilateral vocal fold paralysis commonly report dysphonia and dysphagia. Dyspnea also occurs, with studies on treatment-related change producing mixed results. Studies including patient-reported outcomes have focused on single-questi...

Cord medialisation in unilateral vocal fold paralysis improves forced vital capacity.
https://doi.org/10.1111/coa.13866
Clinical Otolaryngology : Official Journal of ENT-UK ; Of... Thakar A, Pol SA et. al.

Sep 28th, 2021 - The lateralised vocal fold of unilateral vocal fold paralysis (ULVFP) is unphysiological for expiration wherein vocal folds normally adduct to increase expiratory resistance and prevent small airway collapse. ULVFP may therefore impair ventilatory...

Comparison of 24-month voice outcomes after injection laryngoplasty with calcium hydrox...
https://doi.org/10.1016/j.amjoto.2021.103207
American Journal of Otolaryngology; Miaśkiewicz B, Panasiewicz A et. al.

Sep 20th, 2021 - The objective was to evaluate the long-term voice outcomes in pa-tients with unilateral vocal fold paralysis treated with injection laryngoplasty using either cal-cium hydroxylapatite (CaHA) or hyaluronic acid (HA). A single-centre retrospective s...

see more →

Clinicaltrials.gov  3 results

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
https://clinicaltrials.gov/ct2/show/NCT05119842

Nov 15th, 2021 - The APrevent® VOIS is intended to be permanently implanted during a type I thyroplasty in individuals suffering from permanent unilateral vocal fold paralysis of various etiologies. Four post-operative follow-up visits are planned: Week 1 (± 7 day...

Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice
https://clinicaltrials.gov/ct2/show/NCT04713033

Mar 22nd, 2021 - Three experiments will be conducted over the 2-year award period. Experiment 1 (Aim 1) will utilize a 16-channel EMG array to characterize cervical-cranial muscle activity networks in typical speakers at baseline and after a vocal loading task. Ai...

Early UVFP Management Based on Neurological Evidences (UVFP = Unilateral Vocal Fold Paralysis)
https://clinicaltrials.gov/ct2/show/NCT03906877

Oct 22nd, 2020 - The aim of this study is to understand how early intervention could impact reinnervation of the recurrent laryngeal nerve (which innervates the vocal cord), recovery of mobility of the paralyzed vocal cord and / or vocal recovery in the case of un...

see more →